Wolfgang Schatton
About
In The Last Decade
Wolfgang Schatton
23 papers receiving 779 citations
Peers
Comparison fields: 5 of 99
- Molecular Biology 302
- Biomaterials 279
- Biotechnology 197
- Biomedical Engineering 176
- Ocean Engineering 108
Countries citing papers authored by Wolfgang Schatton
This map shows the geographic impact of Wolfgang Schatton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Schatton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Schatton more than expected).
Fields of papers citing papers by Wolfgang Schatton
This network shows the impact of papers produced by Wolfgang Schatton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Schatton. The network helps show where Wolfgang Schatton may publish in the future.
Co-authorship network of co-authors of Wolfgang Schatton
This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Schatton. A scholar is included among the top collaborators of Wolfgang Schatton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Schatton. Wolfgang Schatton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 19 | |
| 4 | 20 | |
| 5 | 11 | |
| 6 | 25 | |
| 7 | 51 | |
| 8 | 76 | |
| 9 | 118 | |
| 10 | 19 | |
| 11 | 63 | |
| 12 | 175 | |
| 13 | 21 | |
| 14 | 13 | |
| 15 | 129 | |
| 16 | Influences of tromantadine and nonoxinol 9 on the stability of red cell membrane. | 3 |
| 17 | 34 | |
| 18 | Bioavailability studies of etofibrate in rhesus monkeys. | 0 |
| 19 | [Atherosclerosis treatment with etofibrate retard. New perspectives]. | 2 |
| 20 | [Pharmacology and mechanism of action of etofibrate]. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.